[1] ENSRUD KE, CRANDALL CJ. Osteoporosis. Ann Intern Med. 2017;167: C17-C32.
[2] JOHNSTON CB, DAGAR M. Osteoporosis in Older Adults. Med Clin North Am. 2020;104:873-884.
[3] CHEN P, LI Z, HU Y. Prevalence of osteoporosis in China: a meta-analysis and systematic review. BMC Public Health. 2016;16:1039.
[4] 李健阳, 葛继荣, 陈娟, 等.2389例绝经后妇女骨量丢失不同阶段的中医证候特征研究[J]. 中华中医药杂志,2021,36(1):389-393.
[5] LI S, CHEN B, CHEN H, et al. Analysis of potential genetic biomarkers and molecular mechanism of smoking-related postmenopausal osteoporosis using weighted gene co-expression network analysis and machine learning. PLoS One. 2021;16:e257343.
[6] 中国健康促进基金会骨质疏松防治中国白皮书编委会.骨质疏松症中国白皮书[J].中华健康管理学杂志,2009,3(3):148-149.
[7] AMARASEKARA DS, YUN H, KIM S, et al. Regulation of Osteoclast Differentiation by Cytokine Networks. Immune Netw. 2018;18:e8.
[8] LI X, QIN L, BERGENSTOCK M, et al. Parathyroid hormone stimulates osteoblastic expression of MCP-1 to recruit and increase the fusion of pre/osteoclasts. J Biol Chem. 2007;282:33098-33106.
[9] 田园, 张智, 顾旖菲, 等.干扰素与骨免疫系统及牙槽骨骨改建的研究进展[J]. 临床口腔医学杂志,2019,35(2):121-123.
[10] 谭荣雄, 蔡杰钦, 李健, 等.单核细胞趋化蛋白-1的形成及其在骨重建中的作用[J]. 海南医学,2021,32(10):1317-1320.
[11] 夏维波,章振林,林华,等.原发性骨质疏松症诊疗指南(2017)[J]. 中国骨质疏松杂志,2019,25(3):281-309.
[12] MANDREKAR JN. Receiver operating characteristic curve in diagnostic test assessment. J Thorac Oncol. 2010;5:1315-1316.
[13] JANSSENS A, MARTENS FK. Reflection on modern methods: Revisiting the area under the ROC Curve. Int J Epidemiol. 2020;49:1397-1403.
[14] KANIS JA. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group. Osteoporos Int. 1994;4:368-381.
[15] ZHAO F, GUO L, WANG X, et al. Correlation of oxidative stress-related biomarkers with postmenopausal osteoporosis: a systematic review and meta-analysis. Arch Osteoporos. 2021;16:4.
[16] BIJELIC R, MILICEVIC S, BALABAN J. Risk Factors for Osteoporosis in Postmenopausal Women. Med Arch. 2017;71:25-28.
[17] HLAING TT, COMPSTON JE. Biochemical markers of bone turnover - uses and limitations. Ann Clin Biochem. 2014;51:189-202.
[18] NAKATSUKA K, NISHIZAWA Y. Biochemical markers for bone metabolism--overview. Nihon Rinsho. 2002;60 Suppl 3:220-227.
[19] 张萌萌, 张岩, 吴涤, 等.骨代谢生化指标实验推荐方案[J]. 中国骨质疏松杂志,2021,27(10):1405-1412.
[20] EVANS AL, PAGGIOSI MA, EASTELL R, et al. Bone density, microstructure and strength in obese and normal weight men and women in younger and older adulthood. J Bone Miner Res. 2015;30:920-928.
[21] MOHR M, HELGE EW, PETERSEN LF, et al. Effects of soccer vs swim training on bone formation in sedentary middle-aged women. Eur J Appl Physiol. 2015;115:2671-2679.
[22] HSU E, PACIFICI R. From Osteoimmunology to Osteomicrobiology: How the Microbiota and the Immune System Regulate Bone. Calcif Tissue Int. 2018;102:512-521.
[23] ILESANMI-OYELERE BL, SCHOLLUM L, KUHN-SHERLOCK B, et al. Inflammatory markers and bone health in postmenopausal women: a cross-sectional overview. Immun Ageing. 2019;16:15.
[24] YANG XW, WANG XS, CHENG FB, et al. Elevated CCL2/MCP-1 Levels are Related to Disease Severity in Postmenopausal Osteoporotic Patients. Clin Lab. 2016;62:2173-2181.
[25] YANG X, ZHOU F, YUAN P, et al. T cell-depleting nanoparticles ameliorate bone loss by reducing activated T cells and regulating the Treg/Th17 balance. Bioact Mater. 2021;6:3150-3163.
[26] 李阳, 芦迪.miR-29及靶基因IFN-γ对痰菌阴性肺结核的诊断价值分析[J]. 中国现代医药杂志,2021,23(9):49-51.
[27] 高金梅, 黄映波, 冯珍珍.单核细胞趋化蛋白-1对67例全身炎症反应综合征患者的诊断价值[J]. 山东大学学报(医学版),2021, 59(10):75-79.
[28] 张银仙, 赵良宇, 方艳玲.TRAb、TSH、IFN-γ和IL-17水平变化在甲状腺功能亢进患者诊断中的应用[J]. 检验医学与临床,2021,18(14): 2068-2071.
[29] 张会强, 文政芳, 张力公, 等.CA125 ADA MCP-1检测对结核性胸腔积液与恶性胸腔积液的诊断价值[J]. 临床心身疾病杂志,2022, 28(1):113-116.
[30] 黄丽丽, 黄文婷, 林庆金, 等.脑脊液IFN-γ、PCT及MMP-9对脑膜炎感染类型的鉴别诊断价值[J]. 脑与神经疾病杂志,2022,30(1):13-17.
[31] ARRON JR, CHOI Y.Bone versus immune system. Nature. 2000;408:535-536.
[32] 张晓红,高艳丽,袁征,等.免疫系统在绝经后骨质疏松症中的作用[J]. 中国骨质疏松杂志,2020,26(10):1538-1541.
[33] GREWAL TS, GENEVER PG, BRABBS AC, et al. Best5: a novel interferon-inducible gene expressed during bone formation. FASEB J. 2000;14: 523-531.
[34] 薛明,杨谛,单风平.白介素-2及干扰素-γ对人成骨细胞增殖的影响[J]. 微生物学杂志,2009,29(4):59-61.
[35] 田园, 张智, 顾旖菲, 等.干扰素与骨免疫系统及牙槽骨骨改建的研究进展[J]. 临床口腔医学杂志,2019,35(2):121-123.
[36] 代飞, 吴军.免疫系统与骨代谢的关系[J]. 第三军医大学学报,2005, 27(2):175-177.
[37] YANG S, MADYASTHA P, RIES W, et al. Characterization of interferon gamma receptors on osteoclasts: effect of interferon gamma on osteoclastic superoxide generation. J Cell Biochem. 2002;84:645-654.
[38] DESHMANE SL, KREMLEV S, AMINI S, et al. Monocyte chemoattractant protein-1 (MCP-1): an overview. J Interferon Cytokine Res. 2009;29: 313-326.
[39] KENKRE JS, BASSETT J. The bone remodelling cycle. Ann Clin Biochem. 2018;55:308-327.
[40] 孙骏, 张磊, 赵威, 等.高糖环境下成骨细胞通过MCP-1/c-fos/NFATC1通路促进破骨细胞分化[J]. 中国医科大学学报,2019,48:683-687.
|